Home

About

Visit

Exhibitions

Programs

Collections

Education

Multimedia

Event Rental

Giving

biotech

Inside Cambridge Biotechnology

Second Tuesdays, February-June, 2014

6:00 - 7:30 p.m.

Admission: $10 adults; $5 students, seniors. Free with MIT ID. Tickets available at the door.

In this new series at the MIT Museum, meet leaders from new and established Cambridge biotechnologies, and learn about the focus and potential impacts of their company’s research.

February 11: David Schenkein, CEO of Agios: Attacking the Deadly Metabolism of Cancer Cells

March 11: George Scangos, CEO of Biogen IDEC: Facing Up To Difficult Diseases

April 8: Kevin Starr, Partner at Third Rock Ventures: The Investment Crisis in Life Science

May 13: John Maraganore, CEO of Alnylam: RNAi Therapeutics, Alnylam Pharmaceuticals, and The Carrot Seed

June 10: Cancelled.

This program is presented in collaboration with Cambridge At Home.